LONDON: The British government adviser has recommended that it does not provide the fourth dose of the Covid-19 vaccine to the occupants of nursing homes and humans more than 80 because data shows that the third shot offered eternal protection against receipts to the hospital.
For people over 65, protection against inpatient care is still around 90% three months after the third dose, according to data compiled by the British health security agency.
As a result, the combined committee of vaccination and immunization on Friday advises the government that no need to offer fourth dose, or the second amplifier, for people who are vulnerable at this time.
Instead, the government must focus on providing the third dose to as many people as possible to improve the protection of an omicron variant that is very contagious.
“Current data shows the booster dose continues to provide a high level of protection against severe diseases, even for the older age group that is most vulnerable,” said Prof.
Wei Shen Lim, Committee’s seat.
“For this reason, the committee has concluded that there is no urgent need to introduce a second booster dose, even though this will continue to be reviewed.” England raced to offer booster shots to adults throughout the country after research showed that two doses were enough to protect people from Omicron.
The variant has triggered a surge in infection and inpatient coronavirus.
The number of people in the UK who was hospitalized with Covid-19 rose to 18,454 on Thursday, more than double the number two weeks earlier.
Absent staff who increase in British hospitals have encouraged the military to provide reserves for bordered doctors and nurses.
More than 39,000 staff members at the UK did not work for reasons related to Covid-19 on January 2, up 59% from the previous week, according to the British NHS.
Respected trade publications, health care journals, said staff absence throughout the NHS, including mental health and regional health, may be as high as 120,000.
Covid-19: British Government Advisor is recommended against the fourth dose of vaccine
